Search Results - Christopher W. Pugh

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    HIFα isoform specific activities drive cell-type specificity of VHL-associated oncogenesis by Joanna D.C.C. Lima, Madeleine Hooker, Ran Li, Ayslan B. Barros, Norma Masson, Christopher W. Pugh, David R. Mole, Julie Adam, Peter J. Ratcliffe, Samvid Kurlekar

    Published in Nature Communications (2025-10-01)
    Get full text
    Article


  2. 2

    Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans. by Tammie Bishop, Kah Weng Lau, Andrew C R Epstein, Stuart K Kim, Min Jiang, Delia O'Rourke, Christopher W Pugh, Jonathan M Gleadle, Martin S Taylor, Jonathan Hodgkin, Peter J Ratcliffe

    Published in PLoS Biology (2004-10-01)
    Get full text
    Article


  3. 3

    Lung Ultrasound Reproducibly Outperforms Computed Tomography in the Detection of Extravascular Lung Water in Patients Undergoing Haemodialysis by John P. Corcoran, Mark Hew, Ben Attwood, Murali Shyamsundar, Sheera Sutherland, Kristine Ventura, Rachel Benamore, Victoria St. Noble, Hania E. Piotrowska, Christopher W. Pugh, Christian B. Laursen, Fergus V. Gleeson, Najib M. Rahman

    Published in Diagnostics (2024-03-01)
    Get full text
    Article


  4. 4

    Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain. by Mun Chiang Chan, Onur Atasoylu, Emma Hodson, Anthony Tumber, Ivanhoe K H Leung, Rasheduzzaman Chowdhury, Verónica Gómez-Pérez, Marina Demetriades, Anna M Rydzik, James Holt-Martyn, Ya-Min Tian, Tammie Bishop, Timothy D W Claridge, Akane Kawamura, Christopher W Pugh, Peter J Ratcliffe, Christopher J Schofield

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  5. 5

    Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. by Thomas G Smith, Jerome T Brooks, George M Balanos, Terence R Lappin, D Mark Layton, Dawn L Leedham, Chun Liu, Patrick H Maxwell, Mary F McMullin, Christopher J McNamara, Melanie J Percy, Christopher W Pugh, Peter J Ratcliffe, Nick P Talbot, Marilyn Treacy, Peter A Robbins

    Published in PLoS Medicine (2006-07-01)
    Get full text
    Article


  6. 6

    Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells by Mike B. Barnkob, Yale S. Michaels, Violaine André, Philip S. Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna Kulicke, Ji-Li Chen, Vitul Jain, Victoria K. Woodcock, Huw Colin-York, Andreas V. Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M. Mazet, Gracie-Jennah Mead, Joshua A. Bull, Pramila Rijal, Christopher W. Pugh, Alain R. Townsend, Audrey Gérard, Lars R. Olsen, Marco Fritzsche, Tudor A. Fulga, Michael L. Dustin, E. Yvonne Jones, Vincenzo Cerundolo

    Published in Nature Communications (2024-04-01)
    Get full text
    Article


  7. 7

    Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells by Mike B. Barnkob, Yale S. Michaels, Violaine André, Philip S. Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna Kulicke, Ji-Li Chen, Vitul Jain, Victoria K. Woodcock, Huw Colin-York, Andreas V. Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M. Mazet, Gracie-Jennah Mead, Joshua A. Bull, Pramila Rijal, Christopher W. Pugh, Alain R. Townsend, Audrey Gérard, Lars R. Olsen, Marco Fritzsche, Tudor A. Fulga, Michael L. Dustin, E. Yvonne Jones, Vincenzo Cerundolo

    Published in Nature Communications (2024-04-01)
    Get full text
    Article


Search Tools: